Ficolin-2: A potential immune-related therapeutic target with low expression in liver cancer

OBJECTIVE: This study aimed to investigate the role of ficolin-2 (FCN2) in the development and course of hepatocellular carcinoma (HCC) and to contribute to the evolution of innovative HCC therapeutics. METHODS: Oncomine, GEPIA (Gene Expression Profiling Interactive Analysis), TISIDB (Tumor Immune S...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Li-ting, Zeng, Qiu-ling, Jiang, Shao-lan, Chen, Zhen-yu, Wang, Xiao-ling, Li, Ling, Li, Xiaolong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679423/
https://www.ncbi.nlm.nih.gov/pubmed/36425563
http://dx.doi.org/10.3389/fonc.2022.987481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679423/
https://www.ncbi.nlm.nih.gov/pubmed/36425563
http://dx.doi.org/10.3389/fonc.2022.987481

Ejemplares similares